Trial Evaluating the Benefit of Left Bundle Branch Area Stimulation Compared With Conventional Pacing in Post-TAVI Atrioventricular Atrioventricular Block
NCT ID: NCT07236489
Last Updated: 2025-12-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
266 participants
INTERVENTIONAL
2025-11-25
2029-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Cardiac resynchronization therapy via biventricular pacing is sometimes proposed as a secondary intervention but involves additional surgery. A newer pacing technique-selective left bundle branch area pacing-has been developed to provide physiological ventricular activation by stimulating conduction pathways distal to the lesion, thereby avoiding dyssynchrony. Retrospective studies suggest clinical benefits, but no prospective randomized trial has yet evaluated its efficacy compared to standard pacing.
The objective of this study is to conduct the first randomized clinical trial comparing left bundle branch area pacing versus conventional right ventricular pacing in patients requiring pacemaker implantation due to atrioventricular block after TAVI.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Central Haemodynamics and Pacing for AV Block
NCT07276490
Management of Patients With New Left Bundle Branch Block After Transcatheter Aortic Valve Implantation
NCT06148883
Left Bundle Branch Area Pacing in Patients After TAVR
NCT05024279
Left Bundle Branch Pacing Versus Right Ventricular Pacing in Patients With Atrioventricular Block
NCT05722379
Left Bundle Branch Area Pacing in Patients With Heart Failure
NCT06488989
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
LBAP : Left Bundle Area Pacing
Pacemaker implantation using left bundle branch area stimulation
Pacemaker implantation using left bundle branch area stimulation
Pacemaker implantation using left bundle branch area stimulation
RVP : Right Ventricular Pacing
Right ventricular pacemaker implantation
Right ventricular pacemaker implantation
Right ventricular pacemaker implantation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Pacemaker implantation using left bundle branch area stimulation
Pacemaker implantation using left bundle branch area stimulation
Right ventricular pacemaker implantation
Right ventricular pacemaker implantation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Preserved left ventricular ejection fraction (LVEF ≥ 50%)
* Indications for pacemaker implantation according to guidelines, including :
* Third-degree atrioventricular (AV) block
* Second-degree AV block Mobitz type 2 or symptomatic Mobitz type 1
* Alternating left and right bundle branch block
* HV interval ≥ 70 ms during electrophysiological study
* Pre-existing right bundle branch block with worsening conduction disturbances post-TAVI
* Prolongation of QRS and PR intervals post-procedure justifying pacemaker implantation
* Signed informed consent
* Patient affiliated with the national health insurance system
Exclusion Criteria
* Contraindication to implantation of an endocardial pacemaker (vascular access issues, sepsis)
* Previously implanted pacemaker
* Patients under legal guardianship, curatorship, or judicial protection
* Participation in another interventional therapeutic clinical trial
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Nantes University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Brest University Hospital
Brest, Finistère, France
Rennes University Hospital
Rennes, Ille-et-Vilaine, France
Tours University Hospital
Tours, Indre-et-Loire, France
Nantes University Hospital
Nantes, Loire-Atlantique, France
Clermont Ferrand University Hospital
Clermont-Ferrand, Puy-de-Dôme, France
Rouen University Hospital
Rouen, Seine-Maritime, France
Poitiers University Hospital
Poitiers, Vienne, France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RC24_0610
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.